A platform for research: civil engineering, architecture and urbanism
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Xu, Wenxuan (author) / Lu, Chunfeng (author) / Zhang, Feng (author) / Shao, Jiangjuan (author) / Yao, Shunyu (author) / Zheng, Shizhong (author)
FEBS JOURNAL ; 284 ; 114-133
2017-01-01
20 pages
Article (Journal)
English
DDC:
572
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
BASE | 2017
|TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
BASE | 2018
|CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Wiley | 2024
|CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Wiley | 2024
|